MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis

Acute myeloid leukemia (AML) is one of the most common hematological malignancies all around the world. MicroRNAs have been determined to contribute various cancers initiation and progression, including AML. Although microRNA-204 (miR-204) exerts anti-tumor effects in several kinds of cancers, its f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiguo, Luo, Hong, Fang, Zehui, Fan, Yanling, Liu, Xiaojuan, Zhang, Yujing, Rui, Shuping, Chen, Yafeng, Hong, Luojia, Gao, Jincheng, Zhang, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177501/
https://www.ncbi.nlm.nih.gov/pubmed/29764561
http://dx.doi.org/10.5483/BMBRep.2018.51.9.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177501/
https://www.ncbi.nlm.nih.gov/pubmed/29764561
http://dx.doi.org/10.5483/BMBRep.2018.51.9.036

Ejemplares similares